Target Name: CCDC86
NCBI ID: G79080
Review Report on CCDC86 Target / Biomarker Content of Review Report on CCDC86 Target / Biomarker
CCDC86
Other Name(s): coiled-coil domain containing 86 | Cytokine-induced protein with coiled-coil domain | CYCLON | cytokine-induced protein with coiled-coil domain | Coiled-coil domain-containing protein 86 | Cyclon | CCD86_HUMAN | cyclon | Coiled-coil domain containing 86

CCDC86: A Potential Drug Target and Biomarker

The protein CCDC86, also known as coiled-coil domain containing 86, is a unique protein that has been identified in various organisms as a potential drug target and biomarker. CCDC86 is a single-pass transmembrane protein that is expressed in most tissues and cells in the body. It plays a critical role in the regulation of cell growth, differentiation, and survival, and is involved in a wide range of physiological processes, including cell signaling, migration, and adhesion.

The CCDC86 protein is characterized by its unique coiled-coil domain, which is a type of protein structure that can alter its stability and function. The coiled-coil domain is responsible for the protein's ability to interact with other proteins and molecules, and for its role in cell signaling. CCDC86 has been shown to play a role in the regulation of cell adhesion, a process that is critical for the development and maintenance of tissues and organs.

In addition to its role in cell signaling, CCDC86 has also been shown to be involved in the regulation of cell growth and differentiation. It has been shown to play a negative role in the regulation of cell proliferation, and to promote theApoptosis (programmed cell death) when cells are treated with certain chemotherapy drugs.

CDC86 has also been shown to be involved in the regulation of cell migration and the development of tissues and organs. It has been shown to play a role in the regulation of cell adhesion and in the development of tissues such as the brain and heart.

The potential drug target for CCDC86 is its role in cell signaling, and its involvement in the regulation of cell growth, differentiation, and survival. CCDC86 has been shown to play a negative role in the regulation of cell proliferation, and to promote theApoptosis when cells are treated with certain chemotherapy drugs. It is also involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs.

CDC86 has also been shown to play a role in the regulation of cell migration and the development of tissues and organs. It has been shown to play a role in the regulation of cell adhesion and in the development of tissues such as the brain and heart.

The potential use of CCDC86 as a drug target is its ability to interact with other proteins and molecules, and its role in the regulation of cell signaling, cell growth, differentiation, and survival. It is also involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs.

In conclusion, CCDC86 is a unique protein that has been identified as a potential drug target and biomarker. Its role in cell signaling, cell growth, differentiation, and survival, as well as its involvement in the regulation of cell adhesion, make it an attractive target for drug development. Further research is needed to fully understand the potential of CCDC86 as a drug and to develop safe and effective treatments.

Protein Name: Coiled-coil Domain Containing 86

The "CCDC86 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC86 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCDC87 | CCDC88A | CCDC88B | CCDC88C | CCDC89 | CCDC9 | CCDC90B | CCDC91 | CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2 | CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2